In recent years, chronic disease areas such as rheumatology have seen a greater emphasis on value-based healthcare and shared decision making in setting treatment goals. Increasingly, patients (and their carers) are considered the core stakeholders in the patient treatment continuum. This is exemplified by the incorporation of patient-reported outcomes (PROs) in disease management. PROs are any reports of health status that the patient makes without clinician influence or interpretation. They have been widely implemented in the clinical trial and drug approvals process, yet they are not regularly used in clinical practice. This symposium will explore how rheumatologists can effectively use PROs to elevate the role of patients as a key stakeholder in the treatment journey. The faculty will share from their experience and clinical practice to provide valuable insight into how PROs can positively impact the care of patients with rheumatological diseases.In addition to a review of commonly-used PROs in rheumatology, the faculty will also seek to describe the value that PROs can add to the treatment journey and ultimately, patient outcomes. Results from clinical trials will be interpreted in light of real-world evidence. Of particular relevance to clinicians practicing in the Asia Pacific region, it is important to ensure that currently-available PRO instruments can capture meaningful information despite the factors that influence patients’ perceptions of health. Our faculty will address this by examining how well existing PROs reflect the views of patients in this region.Up-to-date data will provide a backdrop upon which our experts can shed light on how PROs from clinical and real-world studies are used to guide rheumatologists’ decisions. All in all, this symposium will be a valuable opportunity to gain practical insights into the application of PROs in the day-to-day practice of managing rheumatology patients.